drugset / Trial / NCT07135687
Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction
Phase 4
Not yet recruiting
144 enrolled
Rush University Medical Center
Arthroscopy Association of North America · collab
RandomizedParallel-groupDouble-blindOther
Summary
The purpose of this study to investigate the effect of using losartan (a blood pressure lowering drug with anti-scarring properties) on preventing primary postoperative arthrofibrosis (formation of abnormal scar tissue) in the knees in participants undergoing anterior cruciate ligament (ACL) repair surgery of their knee.
Timeline
- Start
- 2026-08
- Primary completion
- 2028-10
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.